FLNA:BMV
Filana Therapeutics Inc
15,92 MX$
0,00%
(0,00) 1D
5. 10., 12:05:31 GMT-6 · MXN
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro FLNA…
Trž. kap.
36,81 mil.
Prům. obj.
0,00
Objem
0,00
52týd. max.
56,00 MX$
52týd. min.
15,92 MX$
Počet zaměstnanců
19
Trž. kap.
36,81 mil.
Prům. obj.
0,00
Objem
0,00
52týd. max.
56,00 MX$
52týd. min.
15,92 MX$
Počet zaměstnanců
19
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
The Business Journals
·
před 30 minutami
FirstBank CEO rings NYSE bell a decade after IPO as lender eyes future
CNBC
·
před 30 minutami
The bull market turned 4 years old on Monday. Investors say reaching a fifth birthday could be challenging
kalkine.ca
·
před 44 minutami
Which of CCC Intelligent Solutions (NASDAQ:CCC), Alignment Healthcare (NASDAQ:ALHC), First Tracks Biotherapeutics (NASDAQ:TRAX), Victoria's Secret & Co. (NYSE:VSXY) or Fair Isaac (NYSE:FICO) Has the Strongest Verified Catalyst Among Monday's
Yahoo Finance
·
před 5 hodinami
A handful of tech stocks are masking an ugly S&P 500 problem
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Informace o Filana Therapeutics Inc
Generální ředitel-
Zaměstnanci19
Založeno1998
ÚstředíAustin, Texas, Spojené státy americké
Odvětví-